Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Acquired by Rhumbline Advisers
Rhumbline Advisers raised its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 0.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 54,500 shares of the medical research company’s stock after purchasing an additional 264 shares during the period. Rhumbline […]
Rhumbline Advisers raised its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 0.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 54,500 shares of the medical research company’s stock after purchasing an additional 264 shares during the period. Rhumbline […]
